AVNS vs JNJ · rev $687.8M vs P/E 17, rev $49.37B
Avanos Medical Inc (AVNS) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Avanos Medical Inc (AVNS) is a medical devices company listed on NYSE.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported AVNS revenue for 2024-12-31 was $687.8M. Net income was -$392.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. AVNS currently screens at market cap $1.17B.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
AVNS currently screens at market cap $1.17B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the AVNS and JNJ stock pages for the full models.
Not investment advice.